🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Cardiac Injury Due to Anthracycline in Paediatric Oncological Patients

Recruitingn/aAges 0 Years - 18 YearsAllIRCCS Burlo Garofolo
NCT06898320 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study investigates the role of echocardiography and of serum biomarkers (NT-proBNP, cardiac Troponin-I) in predicting cardiac injury in a cohort of paediatric oncological patients treated with Anthracycline chemotherapy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Paediatric oncological patients 0-18 years * Planned start of anthracycline therapy * Normal left ventricular systolic function according to International Guidelines before the treatment with AC Exclusion Criteria: * Previous anthracycline treatment, bone marrow transplantation or chest radiation * Pre-anthracycline treatment echocardiographic evidence of: * More than mild pericardial effusion * More than mild mitral regurgitation * Poor echocardiographic acoustic window
💊

What it tests

  • Not listed
📍

Where

1 site
IRCCS Burlo Garofolo
Trieste, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy